Nova (NVMI) Q1 2026 earnings review
Record Revenues Mask Slight Margin Compression as AI Demand Surges
Nova delivered an exceptionally strong first quarter in 2026, achieving record revenue of $235.3M (up 10% YoY) and beating its own guidance. The growth trajectory is clearly accelerating, driven by robust demand for advanced DRAM and rapid adoption of the Metrion and AncoScene platforms in advanced nodes. While top-line and EPS metrics hit all-time highs, the growth came with a slight cost: non-GAAP gross margins compressed sequentially to 59% from 60%. Q2 2026 guidance points to further acceleration, suggesting the AI-driven capacity build-out easily offsets any lingering geographical headwinds.
🐂 Bull Case
Record revenues from memory devices and advanced logic nodes prove that Nova is securing pivotal design wins as customers transition to Gate-All-Around (GAA) and advanced packaging.
Q2 2026 guidance midpoint of $250M represents a 13.6% YoY growth, demonstrating that the AI-driven semiconductor equipment upcycle has durable momentum.
🐻 Bear Case
Despite breaking revenue records, non-GAAP gross margin stepped down to 59% from 60% in Q4 2025. Rising scale is not currently translating to gross margin expansion.
The company's memory growth relies almost entirely on DRAM and HBM. The NAND segment remains sluggish, acting as a dead weight on broader memory expansion.
⚖️ Verdict: 🟢🟢
Bullish. Nova is perfectly positioned in the fastest-growing segments of the semiconductor market (GAA, DRAM/HBM). The sheer volume of revenue outperformance thoroughly outweighs the minor 100 bps margin compression.
Key Themes
Volume Growth Fails to Lift Gross Margins
A notable contradiction in this quarter's stellar print is the margin profile. Despite sequential revenue growing by over $12M, non-GAAP gross margin fell from 60% in 25Q4 to 59% in 26Q1. While 59% remains within management's historical target model, this negative operating leverage on the gross line suggests less favorable product mix or lingering supply chain/tariff impacts discussed in previous quarters.
Metrion and AncoScene Ramping Rapidly
Specific product innovations are successfully converting to high-volume manufacturing orders. The Metrion platform achieved record sales driven by adoption in memory and logic advanced nodes, while the AncoScene front-end chemical metrology solution hit records due to market share gains and new customer wins. This proves Nova's strategy of expanding beyond pure dimensional metrology is working.
Advanced DRAM Powers Memory Growth
Memory device revenue achieved record highs this quarter. Rather than broad-based memory strength, this is heavily concentrated. Robust demand for advanced DRAM (largely tied to HBM build-outs for AI) is doing the heavy lifting, offsetting ongoing weakness in other memory segments.
AI Serves as the Core Macro Tailwind
Nova's outperformance is directly tethered to the AI super-cycle. WFE investment is shifting rapidly toward Gate-All-Around (GAA) architectures and advanced packaging, both of which require significantly higher metrology intensity. Management explicitly cited this structural shift as the primary catalyst for market outperformance.
Lead Times and Visibility Pressures
In the prior quarter, management flagged 'shorter lead times in China' and broad pressure from customers to accelerate fab deliveries. With Q1 actuals printing strong, Nova appears to be managing this agility challenge well, but shortened visibility inherently increases the risk of sudden order push-outs.
NAND Recovery Still Missing in Action
The massive investments occurring in DRAM and advanced logic cast a shadow over NAND. Management has been waiting for an inflection point in NAND capacity buys for multiple quarters, and Q1 provided no evidence that this recovery has materialized yet.
Other KPIs
Stable. Operating expenses decreased sequentially from $67.5M in 25Q4 to $64.9M in 26Q1, demonstrating disciplined cost control while still scaling revenues. This allowed GAAP operating income to accelerate to $70.8M.
Accelerating. Between cash equivalents ($421.8M), short-term deposits ($333.3M), and marketable securities ($911.2M current/non-current), Nova sits on a massive war chest. Following the $750M convertible note issuance in 2025, this liquidity positions the company perfectly for future M&A in process control.
Guidance
Accelerating. The midpoint of $250M represents sequential growth of 6% and year-over-year growth of 13.6% (compared to $220M in 25Q2). This signals a clear breakout from the $220M-$224M plateau the company hovered at during the middle of FY25.
Accelerating. The midpoint of $2.41 reflects strong sequential expansion from $2.33 in 26Q1, reversing the flat-to-down EPS trend seen throughout late FY25.
Key Questions
Gross Margin Drivers
Non-GAAP gross margin compressed to 59% despite record revenues and scale. Can you break down how much of this was driven by product mix versus lingering supply chain or tariff headwinds?
China Normalization Update
Last quarter, you expected China's revenue share to normalize around 30%. Given the strong Q1 outperformance, how did the geographic mix shake out, and are you seeing the lead-time visibility stabilize?
Capital Deployment Strategy
With liquidity now exceeding $1.6 billion, what is the current timeline and priority list for M&A vs further organic capacity expansion?